Athanassios Kyrgidis
Athanassios Kyrgidis MD, DDS, MSc, PhD, ScD Oral & Maxillofacial - Head & Neck - Skin Cancer Surgeon Fellow in Clinical Pharmacology
Consultant, Department of Oral & Maxillofacial Surgery, Aristotle University of Thessaloniki Specialized Cancer Treatment and Reconstruction Center, General Hospital of Thessaloniki "George Papanikolaou" Leof. Papanikolaou, Pilea Chortiatis 570 10, Thessaloniki, Greece Office: +302313307413 Mobile: +306947566727
Secretary for Continuing Education, Hellenic Association of Oral & Maxillofacial Surgery (HAOMS)
Editor-In-Chief, Hellenic Archives of Oral & Maxillofacial Surgery (HAOMS Journal)
URL: https://www.haomsjournal.org/
Short Rresume:
In 2002 I obtained the degree in Medicine and in 2009 the degree in Dentistry from the Aristotle University of Thessaloniki. In 2008 I received the postgraduate diploma of specialization from the "Medical Research Methodology" of the Department of Medicine, AUTh. From 2005 to 2011 received training in order to receive the medical and dental specialty of Oral & Maxillofacial Surgery. I am also specialized in Emergency Pre-Hospital Medicine from the Training Center of EKAB (2011). I served his military service at the Unorthodox War Training Center (KEAP) of the Special Forces of the Greek Army as a reserve hoplite doctor without specialization (26/5/2003 - 26/5/2004). In 2014 I received after an external committee evaluation from the Research Committee of AUTh the Postdoctoral Fellowship of Excellence during which I prepared Postdoctoral Research on "Study of the immediate and distant morbidity of maxillofacial trauma in the population of Northern Greece” in the the Clinic of Oral & Maxillofacial Surgery of the School of Dentistry. Then, in the years 2015-2016, following an external committee evaluation , I received from the State Scholarship Foundation (IKY) in the context of the out-of-court settlement of the Greek State with Siemens AG, a Postdoctoral Fellowship of Excellence during which I prepared Postdoctoral Research on: “Immune cells in patients treated with bisphosphonates "at the 2nd Laboratory of Pharmacology - Clinical Pharmacology of the Medical School of AUTh. From 2013 to 2018 I was a clinical research fellow at the Italian University Hospital Arcispedale Santa Maria Nuova of Reggio Emiglia where I have participated in protocols of clinical studies and diagnostic accuracy studies and writing systematic reviews and meta-analyzes related to facial skin cancer and head & neck skin diseases in general. I collaborated as a Research Associate (2013-present): at the ENT Clinic and the 2nd Laboratory of Pharmacology (Laboratory of Clinical Pharmacology) of the Department of Medicine, as well as at the Clinic of Oral and Maxillofacial Surgery. During the years 2017-2018, 2018-2019 and 2019-2020 I was an academic fellow in the 2nd Laboratory of Pharmacology (Laboratory of Clinical Pharmacology) of the Department of Medicine of the Aristotle University of Thessaloniki. From September 2020 until today I serve as Consultant of the Greek NHS at the General Hospital of Thessaloniki G. Papanikolaou .
Research projects:
I have participated in 11 international clinical multicenter Studies. Of my published work, 47 papers relate to large-scale clinical trials (over 100-3500 patients). I am a co-author of 8 publications that either describe new criteria for correct disease classification (for Adamantiadi-Behchet disease and for hidradenitis suppurativa) or are clinical guidelines (for Spitz nevi, for atypical Spitz Tumors, for hidradenitis suppurativa, for melanoma, for non-neoplastic skin diseases and for B and T lymphomas) under the auspices of international scientific societies. I have also dealt with systematic reviews, including reviews for the COCHRANE database. I have been participating in the Cochrane Collaboration since 2008, initially as a hand searcher (responsible for the Journal of Oral & Maxillofacial Surgery) and then as an author and later as a principal author and responsible for review. The meta-analysis of my team regarding the benefit of sentinel lymph node biopsy in patients with melanoma was selected in 2015 as a case study by the Cochrane Methods Group (for the correct analysis and documentation of the review and demonstration and recording the systematic errors of the MSLT-I multicenter study included). The research work of the academic faculty members internationally is a point of reference and criterion of international recognition and prestige of the work of a clinic, but also of a Medical School. In this direction, and until January 2021 I have submitted 143 articles that appear in Pubmed, with a total impact factor (Journal Citation Reports) 1263.21 (average 8.77, range 0.467 - 91.245), 3679 citations in Scopus and h-index = 30. From 2008 until today, I have dealt with a number of evidence based medicine issues, especially regarding treatment outcomes and side effects. I have published letters commenting on such actions and their methodological approach in major medical journals (New England Journal of Medicine, Lancet, JAMA, Lancet Oncology, Journal of Clinical Oncology).
